Document is current
Any future updates will be listed below
-
Authors
Bassi, Thiago https://orcid.org/0000-0001-5570-5057
Rohrs E, Elizabeth
Parfait, Melodie
Hannigan, Brett C. https://orcid.org/0000-0001-5778-1686
Reynolds, Steven https://orcid.org/0000-0002-2624-640X
Mayaux, Julien
Decavèle, Maxens
Herrero, Jose https://orcid.org/0000-0001-5969-9678
Demoule, Alexandre
Similowski, Thomas
Dres, Martin https://orcid.org/0000-0001-9191-6089
-
Funding
Funding for this research was provided by:
Lungpacer Medical Inc.
- License Information
-
More Information
Article History
Received: 14 March 2024
Accepted: 14 October 2024
First Online: 18 November 2024
Competing Interests
: The authors declare the following competing interests: T.B.: received a salary from Lungpacer Medical Inc. E.R.: consultant for Lungpacer Medical Inc. B.H.: consultant for Lungpacer Medical Inc. S.R.: co-inventor and received personal fees from Lungpacer Medical Inc., Vancouver, Canada A.D.: Medtronic, grants, personal fees and nonfinancial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants and personal fees from Respinor, grants and nonfinancial support from Lungpacer, outside the submitted work T.S.: reports personal fees for consulting and teaching activities from AstraZeneca France, Chiesi France, KPL consulting, Lungpacer Inc., OSO-AI, TEVA France, Vitalaire. He is a stock shareholder of startups Hephaï and Austral Dx. He is listed as inventor on issued patents (WO2008006963A3, WO2012004534A1, WO2013164462A1) describing EEG responses to experimental and clinical dyspnea. MDr: received personal fees from Lungpacer Medical Inc., Vancouver, Canada and was a member of the Clinical Advisory Board of Lungpacer Medical Inc., Vancouver, Canada. M.P., J.M., M.D., and J.H. declare no competing interests.
